[Influence of extracellular calcium concentration on the effect of coronary dilatators (action mechanism of coronary dilatators)].
D000433:1-Propanol / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001565:Benzoates / Q000494:pharmacology*; D002118:Calcium / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D003331:Coronary Vessels / Q000187:drug effects*; D003374:Coumarins / Q000494:pharmacology; D003998:Dicarboxylic Acids / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D055590:Electromagnetic Phenomena; D005029:Ethylenediamines / Q000494:pharmacology; D005110:Extracellular Space; D006016:Glycolates / Q000494:pharmacology; D006168:Guinea Pigs; D006352:Heart Ventricles / Q000187:drug effects; D009578:Nitrobenzenes / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010477:Perfusion; D010879:Piperazines / Q000037:antagonists & inhibitors; D011299:Prenylamine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D001565:Benzoates; D003374:Coumarins; D003998:Dicarboxylic Acids; D005029:Ethylenediamines; D006016:Glycolates; D009578:Nitrobenzenes; D010879:Piperazines; D011725:Pyridines; D014665:Vasodilator Agents; D000628:Aminophylline; D004176:Dipyridamole; D000433:1-Propanol; D014700:Verapamil; D005996:Nitroglycerin; D011299:Prenylamine; D010100:Oxygen; D002118:Calcium
Uber die Beeinflussung der Wirkung von Coronardilatatoren durch die extracelluläre Calciumkonzentration(ein Beitrag zum Wirkungsmechanismus von Coronardilatatoren.